知镜 Cognispect · 医学文献与研究工作台

Comorbidities of atopic dermatitis: Emerging evidence and clinical considerations.

Zhou J, Margiotta FM, Duca ED, Fiedler J, Cices A, Ungar B, Guttman-Yassky E.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026-04-19 · PMID 42009218

文献摘要

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease and has traditionally been viewed as a disorder confined to the skin. However, emerging epidemiologic, genetic, and mechanistic evidence increasingly supports the concept that AD represents a systemic disease associated with a broad spectrum of immune-related comorbidities. This review synthesizes current literature on the comorbidities associated with AD, including dermatologic, respiratory, gastrointestinal, rheumatologic, neurologic, ophthalmologic, and endocrine disorders. Well-established associations include other atopic diseases such as asthma, allergic rhinitis, food allergy, and eosinophilic esophagitis, reflecting shared type 2 inflammatory pathways and epithelial barrier dysfunction. In addition, increasing evidence links AD with nonatopic autoimmune and immune-mediated conditions, including alopecia areata, chronic spontaneous urticaria, vitiligo, psoriasis, hidradenitis suppurativa, bullous pemphigoid, inflammatory bowel disease, autoimmune thyroid disease, and several rheumatologic disorders. Epidemiologic studies suggest that the risk of autoimmune comorbidity is influenced by AD severity, age, and sex, with more severe AD being associated with a higher risk of comorbidities. Shared pathogenic pathways-including epithelial barrier disruption, T H 2-driven immune activation, impaired immune tolerance, and autoreactive antibody responses-may underlie these associations. Recognition of these comorbidities has important implications for clinical practice, including early identification of systemic disease, multidisciplinary management, and selection of targeted therapies, including biologics and Janus kinase inhibitors, that may address overlapping inflammatory pathways. Improved understanding of these relationships may inform personalized treatment strategies and guide future research into shared mechanisms linking atopy and autoimmunity.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。